Virus burden in human immunodeficiency virus type 1-infected children: relationship to disease status and effect of antiviral therapy

Pediatrics. 1991 Jun;87(6):921-5.

Abstract

The human immunodeficiency virus type 1 (HIV-1) was isolated from the plasma and peripheral blood mononuclear cells (PBMCs) from each of 21 infected children. The mean titers in plasma were 7 and 165 tissue culture-infective doses per milliliter in 9 children with asymptomatic (P-1) and 12 with symptomatic (P-2) infection, respectively (P = .0013). Significantly higher viral titers were found in PBMCs obtained from P-2 compared with P-1 children: 1920 vs 25 tissue culture-infective doses per 10(6) PBMC (P = .0018). In symptomatic patients at least 1 in 520 circulating mononuclear cells harbored HIV-1. No correlation was found between the viral burden and CD4+ lymphocyte counts. A decrease in the HIV-1 titers was noted both in PBMCs and plasma of symptomatic patients treated with zidovudine for 2 to 7 months. It is concluded that symptomatic children harbor a higher amount of the virus in plasma and PBMCs than asymptomatic children. Zidovudine treatment for 2 months or more decreased the amount of HIV-1 in PBMCs and plasma.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy
  • Acquired Immunodeficiency Syndrome / etiology
  • Acquired Immunodeficiency Syndrome / microbiology*
  • Adolescent
  • Body Burden
  • CD4 Antigens / isolation & purification
  • Cells, Cultured
  • Child
  • Child, Preschool
  • HIV-1 / isolation & purification*
  • Humans
  • Infant
  • Infant, Newborn
  • Transfusion Reaction
  • Zidovudine / therapeutic use

Substances

  • CD4 Antigens
  • Zidovudine